BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 24828487)

  • 1. Differences in the recurrence and mortality outcomes rates of incidental and nonincidental papillary thyroid microcarcinoma: a systematic review and meta-analysis of 21 329 person-years of follow-up.
    Mehanna H; Al-Maqbili T; Carter B; Martin E; Campain N; Watkinson J; McCabe C; Boelaert K; Franklyn JA
    J Clin Endocrinol Metab; 2014 Aug; 99(8):2834-43. PubMed ID: 24828487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and pathological characteristics of incidental and nonincidental papillary thyroid microcarcinoma in 339 patients.
    Vasileiadis I; Karatzas T; Vasileiadis D; Kapetanakis S; Charitoudis G; Karakostas E; Kouraklis G
    Head Neck; 2014 Apr; 36(4):564-70. PubMed ID: 23780707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Papillary thyroid carcinoma and microcarcinoma: is there a need to distinguish the two?
    Arora N; Turbendian HK; Kato MA; Moo TA; Zarnegar R; Fahey TJ
    Thyroid; 2009 May; 19(5):473-7. PubMed ID: 19348582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Papillary Thyroid Microcarcinoma: Differences between Lesions in Incidental and Nonincidental Settings-Considerations on These Clinical Entities and Personal Experience.
    Lucandri G; Fiori G; Falbo F; Pende V; Farina M; Mazzocchi P; Santonati A; Bosco D; Spada A; Santoro E
    Curr Oncol; 2024 Feb; 31(2):941-951. PubMed ID: 38392064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for nodal metastasis and recurrence among patients with papillary thyroid microcarcinoma: differences in clinical relevance between nonincidental and incidental tumors.
    Pisanu A; Reccia I; Nardello O; Uccheddu A
    World J Surg; 2009 Mar; 33(3):460-8. PubMed ID: 19123022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidental versus clinical diagnosis of papillary thyroid microcarcinoma. Long-term prognosis.
    Ruiz J; Ríos A; Rodríguez JM; Paredes M; Soriano V; Oviedo MI; Hernández AM; Parrilla P
    Endocrinol Diabetes Nutr (Engl Ed); 2020 May; 67(5):317-325. PubMed ID: 31882257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors contributing to the difference in prognosis for papillary versus micropapillary thyroid carcinoma.
    Karatzas T; Vasileiadis I; Kapetanakis S; Karakostas E; Chrousos G; Kouraklis G
    Am J Surg; 2013 Oct; 206(4):586-93. PubMed ID: 23790258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk Factors of Metastatic Lymph Nodes in Papillary Thyroid Microcarcinoma.
    Ruiz Pardo J; Ríos A; Rodríguez JM; Paredes M; Soriano V; Oviedo MI; Hernández AM; Parrilla P
    Cir Esp (Engl Ed); 2020 Apr; 98(4):219-225. PubMed ID: 31980154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidental and nonincidental papillary thyroid microcarcinoma.
    Lin JD; Kuo SF; Chao TC; Hsueh C
    Ann Surg Oncol; 2008 Aug; 15(8):2287-92. PubMed ID: 18483830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Papillary thyroid microcarcinoma: extrathyroidal extension, lymph node metastases, and risk factors for recurrence in a high prevalence of goiter area.
    Lombardi CP; Bellantone R; De Crea C; Paladino NC; Fadda G; Salvatori M; Raffaelli M
    World J Surg; 2010 Jun; 34(6):1214-21. PubMed ID: 20052467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Retrospective comparison of screening criteria for active surveillance for papillary thyroid microcarcinoma].
    Qian K; Sun TQ; Guo K; Zheng XK; Li DS; Wei WW; Wu Y; Ji QH; Wang ZY
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jun; 52(6):430-434. PubMed ID: 28635215
    [No Abstract]   [Full Text] [Related]  

  • 12. Management of cN0 papillary thyroid microcarcinoma patients according to risk-scoring model for central lymph node metastasis and predictors of recurrence.
    Feng JW; Ye J; Wu WX; Qu Z; Qin AC; Jiang Y
    J Endocrinol Invest; 2020 Dec; 43(12):1807-1817. PubMed ID: 32557354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Papillary thyroid microcarcinoma: prognostic factors and treatment.
    Besic N; Pilko G; Petric R; Hocevar M; Zgajnar J
    J Surg Oncol; 2008 Mar; 97(3):221-5. PubMed ID: 18050283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and Pathologic Predictors of Lymph Node Metastasis and Recurrence in Papillary Thyroid Microcarcinoma.
    Siddiqui S; White MG; Antic T; Grogan RH; Angelos P; Kaplan EL; Cipriani NA
    Thyroid; 2016 Jun; 26(6):807-15. PubMed ID: 27117842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radioactive iodine ablation does not prevent recurrences in patients with papillary thyroid microcarcinoma.
    Kim HJ; Kim NK; Choi JH; Kim SW; Jin SM; Suh S; Bae JC; Min YK; Chung JH; Kim SW
    Clin Endocrinol (Oxf); 2013 Apr; 78(4):614-20. PubMed ID: 22957654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Papillary thyroid microcarcinoma. Long-term outcome in 587 cases compared with published data].
    Pelizzo MR; Merante Boschin I; Toniato A; Piotto A; Bernante P; Pagetta C; Casal Ide E; Mazzarotto R; Casara D; Rubello D
    Minerva Chir; 2007 Oct; 62(5):315-25. PubMed ID: 17947943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bilateral versus unilateral papillary thyroid microcarcinoma: predictive factors and associated histopathological findings following total thyroidectomy.
    Karatzas T; Vasileiadis I; Charitoudis G; Karakostas E; Tseleni-Balafouta S; Kouraklis G
    Hormones (Athens); 2013; 12(4):529-36. PubMed ID: 24457401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological Features and Prognosis of Papillary Thyroid Microcarcinoma for Surgery and Relationships with the BRAFV600E Mutational Status and Expression of Angiogenic Factors.
    Shi C; Guo Y; Lv Y; Nanding A; Shi T; Qin H; He J
    PLoS One; 2016; 11(12):e0167414. PubMed ID: 27936049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural history, diagnosis, treatment and outcome of papillary thyroid microcarcinoma (PTMC): a mono-institutional 12-year experience.
    Pelizzo MR; Boschin IM; Toniato A; Pagetta C; Piotto A; Bernante P; Casara D; Pennelli G; Rubello D
    Nucl Med Commun; 2004 Jun; 25(6):547-52. PubMed ID: 15167512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk Factors for Central Compartment Lymph Node Metastasis in Papillary Thyroid Microcarcinoma: A Meta-Analysis.
    Qu N; Zhang L; Ji QH; Chen JY; Zhu YX; Cao YM; Shen Q
    World J Surg; 2015 Oct; 39(10):2459-70. PubMed ID: 26099728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.